The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 8th 2024
An interim analysis of the PRO-SPIRIT study compared outcomes at 3 months after starting new treatments for psoriatic arthritis.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Good Information Lacking on Pain Relief for Inflammatory Arthritis
January 11th 2013Pain is the main problem that sends patients to rheumatologists, but studies of medication for rheumatic disorders such as RA have focused on inflammation, not pain. A review points out what is not known currently about analgesia in inflammatory arthritis and urgently needs to be studied.
Occult Spinal Abscesses After Contaminated Injection Cause CDC to Heighten Warnings
December 23rd 2012Patients whose back pain has not eased or has worsened after contaminated spinal injections should have MRIs to look for abscesses or other signs of latent infection, the Centers for Disease Control and Prevention has advised.
Why Do Many African Americans Resist Treatments for Arthritis?
December 18th 2012A closer look at racial disparities in treatments for rheumatoid arthritis and osteoarthritis show nuanced explanations for why African Americans are less willing to undergo drug therapy and surgery. More careful and clearer communication may go a long way toward closing the gap.
Fractures in RA Patients Foreshadow Cardiovascular and Mortality Risk
December 14th 2012The reasons for the association aren't yet clear, but experts are warning that you should consider a fracture a red flag for cardiovascular risk in a patient with rheumatoid arthritis. Fractures also are associated with an increased mortality risk in general among RA patients.
Balancing Risks and Benefits When Treating Chronic Pain with Opioids
December 13th 2012Lynn Webster, MD, President-elect of the American Academy of Pain Medicine (AAPM) talks about the petition submitted to the FDA by Physicians for Responsible Opioid Prescribing (PROP) and the AAPM response; the current dialogue on the risks and benefits of prescription opioids for managing chronic noncancer pain; and the future of pain management.
5 Things I Wish I Learned in Medical School about Managing Pain
December 12th 2012With most medical schools devoting only a few curriculum hours to pain management training, many physicians begin their medical career underprepared to meet the needs of patients suffering with chronic pain. Here, Barry Cole, MD, identifies several key concepts that would help improve pain care in the US if only more physicians would learn about them sooner.
RF Versus ACPA in Assessing Rheumatoid Arthritis
December 7th 2012(VIDEO) With rising attention to anti-citrullinated protein antibodies (ACPA) in RA classification, what is the current significance of rheumatoid factor? Rheumatologist Josef Smolen tells how he and others at the Medical University of Vienna addressed the question.
ACR2012 Highlights: Predictors of Osteoarthritis Outcome
December 6th 2012Among presentations on OA at last month’s American College of Rheumatology meeting, several described ways of identifying or predicting disease status and progression-through imaging, clinical features, and biochemical markers.
Neurobiological and Neuropsychiatric Mechanisms of Fibromyalgia and Their Implications for Treatment
December 3rd 2012The variety of mechanisms that play a part in pathologic pain perception leads to a great deal of complexity and variation in the clinical presentation and severity of fibromyalgia symptoms, as well as a high degree of variability in patient response to treatment.
New Insights Into Why RA Patients and Their Doctors Disagree
November 30th 2012Refining the ample evidence that rheumatologists and their rheumatoid arthritis patients disagree on the severity of symptoms, new studies reported at ACR2012 point toward better definitions of disease status, and a way to identify patients for whom treatment targets may need to be reconsidered.